CYTORA presents Phase I/IIa clinical trial diabetic foot ulcer (DFU) results at the Israeli Society of Gene and Cell Therapy held at Bar Ilan University, Sept 10, 2025

Cytora were proud to share Phase I/IIa DFU results demonstrating both safety and efficacy with meaningful potential for DFU patients. The results were presented by Cytora CEO Dr. Yona Geffen, with a poster presented by Sari Alon and Haim Goltsman.

​

We are encouraged by the positive feedback, reflecting both the promise of Cytora’s innovation and the dedication of our team.